This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
25 Oct 2011

Sanofi Appoints David Meeker as CEO of Genzyme

Under Mr. Meeker’s leadership, Genzyme will incorporate the Rare Disease business and the Multiple Sclerosis franchise.

French drugmaker Sanofi has appointed David Meeker as chief executive officer of Genzyme, a Sanofi company, effective November 1, 2011.

 

Mr. Meeker will report to Christopher A. Viehbacher, chief executive officer of Sanofi, and will join the Group Management Committee. Christopher A. Viehbacher will retain the position of chairman, Genzyme.

 

Under Mr. Meeker’s leadership, Genzyme will incorporate the Rare Disease business and the Multiple Sclerosis franchise. Previous Genzyme divisions, Renal, Biosurgery and Oncology, have been integrated within the existing Sanofi portfolio to give them greater global scale and capabilities.

 

Mr. Meeker join

Related News